Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Family businesses in India, with their multigenerational legacies, strong domestic brands and loyal customers, have become ...

SINGAPORE - Media OutReach Newswire - 12 July 2025 - A significant advancement in weight management has arrived for Singaporeans. Novo Nordisk, a global healthcare company focused on defeating serious ...

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...

Singapore's state investor Temasek is looking to invest more in Indian family-run businesses, a top executive said ...

Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...

The Europe GLP-1 agonists market, valued at USD 7.09 billion in 2024, is set to grow at a 17.30% CAGR, reaching USD 14.34 billion by 2034. Driven by ...

Imugene (ASX:IMU) will forge ahead with a planned pivotal US trial for its blood cancer therapy Azer-cel, having recorded ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the start.

“At Novo Nordisk, we understand the critical importance of collaboration in advancing cardio care,” said Melvin D'Souza, General Manager at Novo Nordisk Saudi Arabia.“Our partnership with the Saudi ...

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...